EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TrkA Expression as a Novel Prognostic Biomarker in Oral Squamous Cell Carcinoma

Aleksandra Ciarka iD, Filip Skowronek, Przemysław Miłosz, Michał Kunc iD, Robert Burdach, Monika Sakowicz-Burkiewicz, Barbara Jereczek-Fossa, Anna Starzyńska iD, Rafał Pęksa iD

International Journal of Molecular Sciences · 16.07.2025 · 26 (14) · 6847

DOI: 10.3390/ijms26146847 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.07.2025. Verfasst von Aleksandra Ciarka und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathomorphology, Medical University of Gdansk, 7 Dębinki Street, 80-211 Gdańsk, Poland. Hauptthemen laut MEDLINE: Receptor, trkA, Mouth Neoplasms, Biomarkers, Tumor, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral squamous cell carcinoma (OSCC) remains a significant global health challenge, representing 90% of oral malignancies. Despite therapeutic advances, patient outcomes remain poor, highlighting the need for novel prognostic biomarkers and treatment targets. We investigated the expression patterns of NTRK genes and their corresponding proteins (TrkA, TrkB, and TrkC) in OSCC, analyzing their relationships with clinical outcomes and potential as therapeutic targets. We examined 93 OSCC tissue samples using immunohistochemistry and quantitative real-time PCR. Protein expression was quantified using the H-score method. We analyzed correlations between Trk expression, clinicopathological parameters, and 2-year survival rates using chi-square tests, Mann–Whitney U tests, and Kaplan–Meier survival analysis. TrkA showed near-universal expression (97.8%—91 patients) in OSCC samples, with high expression levels significantly correlating with lower tumor grade (p = 0.014) and improved 2-year survival (p = 0.011). While TrkB and TrkC were expressed in 65.5% and 84.9% of cases, respectively, neither showed significant associations with clinical parameters. NTRK2 and NTRK3 mRNA levels demonstrated a strong positive correlation (R = 0.64, p = 0.002), suggesting coordinated regulation. Our findings establish TrkA as a promising positive prognostic marker in OSCC, warranting investigation as a therapeutic target. The strong correlation between NTRK2 and NTRK3 expression suggests shared regulatory mechanisms in OSCC pathogenesis. Further studies with larger cohorts and longer follow-up periods are needed to validate these findings and explore their therapeutic implications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, trkAMouth NeoplasmsBiomarkers, TumorCarcinoma, Squamous CellHumansMaleFemaleMiddle AgedPrognosisAgedAdultReceptor, trkBGene Expression Regulation, NeoplasticReceptor, trkCAged, 80 and overKaplan-Meier EstimateMembrane Glycoproteins

Stichwörter der Autor:innen

NTRKTrkAbiomarkeroral squamous cell carcinomaprognosis

Substanzen

Receptor, trkABiomarkers, TumorReceptor, trkBNTRK1 protein, humanReceptor, trkCtropomyosin-related kinase-B, humanMembrane Glycoproteins

Autor:innen und Institutionen

  • Department of Pathomorphology, Medical University of Gdansk, 7 Dębinki Street, 80-211 Gdańsk, Poland.
  • Student Scientific Circle, Department of Cardiac Surgery, Medical University of Silesia, 15 Poniatowski Street, 40-055 Katowice, Poland.
  • Student Scientific Circle, Department of Pathomorphology, Medical University of Gdansk, 7 Dębinki Street, 80-211 Gdańsk, Poland.
  • Department of Oral Surgery, Medical University of Gdansk, 7 Dębinki Street, 80-211 Gdansk, Poland.
  • Department of Molecular Medicine, Medical University of Gdansk, 7 Dębinki Street, 80-211 Gdansk, Poland.
  • Department of Oncology and Hemato-Oncology, University of Milan, 7 Festa del Perdono Street, 20-112 Milan, Italy.

ORCID-Profile: Aleksandra Ciarka, Michał Kunc, Anna Starzyńska, Rafał Pęksa

Zitieren

APA

Ciarka, A., Skowronek, F., Miłosz, P., Kunc, M., Burdach, R., Sakowicz-Burkiewicz, M., Jereczek-Fossa, B., Starzyńska, A., & Pęksa, R. (2025). TrkA Expression as a Novel Prognostic Biomarker in Oral Squamous Cell Carcinoma. International Journal of Molecular Sciences, 26(14), 6847. https://doi.org/10.3390/ijms26146847

Vancouver

Ciarka A, Skowronek F, Miłosz P, Kunc M, Burdach R, Sakowicz-Burkiewicz M, et al. TrkA Expression as a Novel Prognostic Biomarker in Oral Squamous Cell Carcinoma. International Journal of Molecular Sciences. 2025;26(14):6847. doi:10.3390/ijms26146847

BibTeX
@article{Ciarka2025,
  author = {Ciarka, Aleksandra and Skowronek, Filip and Miłosz, Przemysław and Kunc, Michał and Burdach, Robert and Sakowicz-Burkiewicz, Monika and Jereczek-Fossa, Barbara and Starzyńska, Anna and Pęksa, Rafał},
  title = {TrkA Expression as a Novel Prognostic Biomarker in Oral Squamous Cell Carcinoma},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {14},
  pages = {6847},
  doi = {10.3390/ijms26146847}
}
Kostenlos starten →